Form: S-1/A

General form of registration statement for all companies including face-amount certificate companies

January 10, 2025

Documents

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

FibroBiologics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security

Type

   Security Class Title  

Fee Calculation

Rule

  

Amount

Registered

(1)  

Proposed

Maximum

Offering

Price Per

Unit

    

Maximum

Aggregate

Offering Price

     Fee Rate    

Amount of

Registration

Fee

  
Fees Previously Paid                                                
Equity   Common stock, par value $0.00001 per share   Rule 457(c)     4,343,220 (2)   $ 2.315 (2)   $ 10,054,554.30       153.10 per $1,000,000     $ 1,539.35  
                                                 
Equity   Common stock, par value $0.00001 per share, underlying convertible promissory notes   Rule 457(c)     36,945,813 (2)   $ 2.315 (2)   $ 85,529,557.10       153.10 per $1,000,000     $ 13,094.58  
Fees to be Paid                                                
    Common stock, par value $0.00001 per share   Rule 457(c)     200,549     $ 2.17 (3)   $ 435,191.33       153.10 per $1,000,000     $ 66.63  
                                                 
Total Offering Amounts             $ 96,019,302.73             $ 14,700.56  
Total Fees Previously Paid             $ 95,584,111.40               14,633.93  
Total Fee Offsets                               —  
Net Fee Due             $  435,191.33             $ 66.63  

 

  (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement on Form S-1 shall be deemed to cover any additional shares of common stock, par value $0.00001 per share, or the Common Stock, of FibroBiologics, Inc. that may be issued as a result of any stock dividend, stock split, recapitalization or other similar transaction, and any other securities with respect to which the outstanding shares are converted or exchanged.
     
  (2) Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average of the high and low sales price of Common Stock as reported on the Nasdaq Global Market on December 27, 2024.
     
  (3) Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act, based on the average of the high and low sales price of Common Stock as reported on the Nasdaq Global Market on January 9, 2025.